Human chorionic gonadotropin is a naturally occurring hormone produced by the trophoblast glands surrounding an ovulating woman's developing fetus, which forms the egg cell during fertilization. The presence of human chorionic gonadotropin is commonly detected in early pregnancy tests. Some women who are tested negative for human chorionic gonadotropin are then advised to take additional tests to confirm human chorionic gonadotropin pregnancy. A positive result from one such test indicates that human chorionic gonadotropin may be the primary hormone secreted in the pregnant woman. Other tests include testing of serum creatinine, follicle stimulating hormone, and estrogen levels in urine.
The primary means of determining the levels of human chorionic gonadotropin in patients with suspected human chorionic gonadotropin pregnancy loss is measurement of follicle stimulating hormone levels in the urine. Serum follicle stimulating hormone does not indicate pregnancy but helps in confirming the diagnosis of her pregnancy. Women with prolonged monitoring during their pregnancy may develop higher follicle stimulating hormone levels and thus better detectable levels of human chorionic gonadotropin. Higher follicle stimulating hormone levels are predictive of early pregnancy and hence help in choosing the best healthcare provider.
An ultrasound or magnetic resonance is another method used to detect low levels of human chorionic gonadotropin in pregnant patients. In this method, small magnetic particles are introduced into the patient's body, which travel through the blood stream to the pituitary gland, stimulating it to produce more follicle stimulating hormone. Magnetic resonance utilizes ultrasound waves to excite nearby cells and stimulate them, resulting in enhanced levels of follicle stimulating hormone and increased production of her. The additional stimulation helps to increase the survival and development of the fetus inside the womb. This method also helps to reduce the birth weight of the child born to women with human chorionic gonadotropin during their pregnancy.
Human chorionic gonadotropin is widely used to treat women suffering from endometriosis or polycystic ovaries. This hormone can be used to treat many female reproductive system ailments, including infertility and hormonal imbalance. Low levels of this hormone have been associated with a number of reproductive cancers, including breast cancer, colon cancer, ovarian cancer, and vaginal cancer. Human chorionic gonadotropin can also be used for fertility treatments in male patients who have a decreased ability to produce testosterone. This may improve fertility by improving sperm count and improving sperm quality. The hormone may also improve male sexual potency. It has also been used to treat low sperm count, a condition that may impair male fertility.
Smaller amounts of HCG are also produced in the pituitary gland, the liver, and the colon. Moreover, human chorionic gonadotropin is often prescribed as part of hormonal therapy when a woman has ovulated but has failed to get pregnant after one complete cycle of fertility treatment. The HCG helps with fertility issues since it stimulates the production of eggs from the ovaries, which increases the likelihood of getting pregnant. Human chorionic gonadotropin is used to cause ovulation and to treat infertility in women, and to increase sperm count in men.